Scholarlink

Background <p>The integration of mobile health technology with physical visits shows promising one-year treatment outcomes, but long-term evidence is lacking.</p> Objectives <p>To assess three-year treatment outcomes for patients utilizing the digital treatment tool Evira in combination with physical visits, compared with standard obesity care.</p> Methods <p>In a pragmatic trial, children with obesity aged 4.0–17.9 years receiving digi-physical treatment with Evira (<i>n</i> = 107) were compared with a group receiving standard treatment (<i>n</i> = 321). Evira comprises a digitless body scale for home-weighing, a mobile application, and a web-based clinic interface, enabling easy family-clinic communication and continuous visual treatment feedback.</p> Results <p>At the three-year follow-up, the adjusted average change in body mass index Z-score was –0.29 [95% confidence interval: –0.40, –0.18] units in the digi-physical treatment group vs. –0.12 [–0.21, –0.03] in the standard treatment group, <i>p</i> = 0.02, and 31.8% vs. 18.7% obtained obesity remission respectively, <i>p</i> = 0.0046.</p> Conclusion <p>Over a three-year period, the digi-physical treatment generated superior treatment effect and higher obesity remission rate than standard treatment.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Long-term results of a digital treatment tool as an add-on to pediatric obesity lifestyle treatment: a 3-year pragmatic clinical trial

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年3月12日

查看全文
  • Emilia Hagman,
  • Louise Lindberg,
  • Resthie R. Putri,
  • Andreas Drangel,
  • Claude Marcus,
  • Pernilla Danielsson

摘要

Background

The integration of mobile health technology with physical visits shows promising one-year treatment outcomes, but long-term evidence is lacking.

Objectives

To assess three-year treatment outcomes for patients utilizing the digital treatment tool Evira in combination with physical visits, compared with standard obesity care.

Methods

In a pragmatic trial, children with obesity aged 4.0–17.9 years receiving digi-physical treatment with Evira (n = 107) were compared with a group receiving standard treatment (n = 321). Evira comprises a digitless body scale for home-weighing, a mobile application, and a web-based clinic interface, enabling easy family-clinic communication and continuous visual treatment feedback.

Results

At the three-year follow-up, the adjusted average change in body mass index Z-score was –0.29 [95% confidence interval: –0.40, –0.18] units in the digi-physical treatment group vs. –0.12 [–0.21, –0.03] in the standard treatment group, p = 0.02, and 31.8% vs. 18.7% obtained obesity remission respectively, p = 0.0046.

Conclusion

Over a three-year period, the digi-physical treatment generated superior treatment effect and higher obesity remission rate than standard treatment.